Alpine Associates Advisors’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Alpine Associates Advisors’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-931,109	Closed	-$5.86M	–	100
2013 Q2	$5.86M	Buy	+931,109	New	+$5.58M	0.24%	60

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Alpine Associates Advisors's PBTH Position: Q3 2013 in Review

Alpine Associates Advisors sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 931,109 shares — an estimated $5.86M sold.

Alpine Associates Advisors first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $5.86M in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Alpine Associates Advisors reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Alpine Associates Advisors sold 931,109 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $5.86M.
Alpine Associates Advisors first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Alpine Associates Advisors's PROLOR Biotech, Inc. Common Stock position peaked at $5.86M in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Alpine Associates Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.